Roche, Hansoh Launch Up-to-$15B+ Cancer ADC Collaboration

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 20 Oct, 19:38 UTC

The companies' strategic collaboration will consist of two preclinical Hansoh ADC programs and “multiple” ADC programs based on Roche-identified targets, to be developed through Hansoh’s ADC technology platform. The post Roche, Hansoh Launch Up-to-$15B+ Cancer ADC Collaboration appeared first on…

science

Sources

• T2Roche, Hansoh Launch Up-to-$15B+ Cancer ADC CollaborationFierce Biotech / Fierce Healthcare / MedCity / GEN20 Oct, 19:38